Your browser is no longer supported. Please, upgrade your browser.
Settings
FTXH [NASD]
First Trust Nasdaq Pharmaceuticals ETF
Index- P/E- EPS (ttm)- Insider Own- Shs Outstand- Perf Week1.68%
Market Cap- Forward P/E- EPS next Y- Insider Trans- Shs Float- Perf Month-0.28%
Income- PEG- EPS next Q- Inst Own- Short Float- Perf Quarter-2.34%
Sales- P/S- EPS this Y- Inst Trans- Short Ratio- Perf Half Y8.17%
Book/sh- P/B- EPS next Y- ROA- Target Price- Perf Year19.97%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range21.32 - 27.16 Perf YTD1.58%
Dividend0.23 P/FCF- EPS past 5Y- ROI- 52W High-3.62% Beta-
Dividend %0.88% Quick Ratio- Sales past 5Y- Gross Margin- 52W Low22.78% ATR0.32
Employees- Current Ratio- Sales Q/Q- Oper. Margin- RSI (14)59.03 Volatility0.73% 1.01%
OptionableNo Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume0.16 Prev Close25.83
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume12.21K Price26.18
Recom- SMA202.48% SMA500.95% SMA2004.46% Volume1,907 Change1.33%
Nov-11-20 08:00AM  
Feb-07-20 11:05AM  
Nov-06-19 11:00AM  
Sep-24-19 05:27PM  
Aug-07-19 10:59AM  
May-09-19 10:05AM  
Mar-01-19 08:00AM  
Feb-28-19 04:43PM  
Feb-07-19 11:15AM  
Jan-23-19 02:04PM  
Oct-24-18 11:59AM  
Oct-12-18 06:00AM  
Jan-26-18 09:02AM  
Jan-12-18 07:31AM  
Jan-01-18 07:33AM  
Sep-12-17 10:36AM  
Sep-04-17 09:06AM  
Sep-01-17 07:38AM  
Aug-30-17 09:07AM  
Aug-11-17 03:59PM  
May-05-17 09:59AM  
Mar-22-17 05:25PM  
Dec-09-16 09:36AM  
Oct-25-16 03:04PM  
Oct-20-16 08:07AM  
Oct-14-16 12:04PM  
Sep-28-16 09:00AM  
Sep-27-16 09:00AM  
Sep-22-16 01:55PM  
Sep-21-16 09:12AM  
The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of the Nasdaq US Smart Pharmaceuticals Index. The fund will normally invest at least 90% of its net assets (including investment borrowings) in the common stocks and depository receipts that comprise the index. The index is designed to provide exposure to U.S. companies comprising the pharmaceutical sector that have been selected based upon their liquidity and weighted based upon their cumulative score on three investing factors: volatility, value and growth. It is non-diversified.